PATENT CLAIM ANALYSIS

Application Number: 15879042
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "583000"]

Abstract:
Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.

Claim (Index 21):
The method of  claim 18 , wherein the composition is a solid dosage form.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 86.0
- Lexical Diversity: 1.58333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13802359', '15636227', '13453765', '11528902', '14848148']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8354411755545365
- 35 USC 102 Novelty (BERT): 0.5688438110970873
- Combined Prediction Score: 0.8087814391087915
- Mean Citation Score: 576.64046
- Max Citation Score: 580.2708
- Similarity Product: 339.8615496964216

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test